title: ACR Appropriateness Criteria® growth disturbances - risk of intrauterine growth restriction.
abstract: Fetal growth disturbances include fetuses at risk for intrauterine growth restriction. These fetuses may have an estimated fetal weight at less than the 10% or demonstrate a plateau of fetal growth with an estimated fetal growth greater than the 10%. Uteroplacental insufficiency may play a major role in the etiology of intrauterine growth restriction. Fetuses at risk for intrauterine fetal growth restriction are susceptible to the potential hostility of the intrauterine environment leading to fetal hypoxia and fetal acidosis. Fetal well-being can be assessed using biophysical profile, Doppler velocimetry, fetal heart rate monitoring, and fetal movement counting.Fetal growth disturbances include fetuses at risk for intrauterine growth restriction. These fetuses may have an estimated fetal weight at less than the 10% or demonstrate a plateau of fetal growth with an estimated fetal growth greater than the 10%. Uteroplacental insufficiency may play a major role in the etiology of intrauterine growth restriction. Fetuses at risk for intrauterine fetal growth restriction are susceptible to the potential hostility of the intrauterine environment leading to fetal hypoxia and fetal acidosis. Fetal well-being can be assessed using biophysical profile, Doppler velocimetry, fetal heart rate monitoring, and fetal movement counting.The ACR Appropriateness Criteria® are evidence-based guidelines for specific clinical conditions that are reviewed every two years by a multidisciplinary expert panel. The guideline development and review include an extensive analysis of current medical literature from peer reviewed journals and the application of a well-established consensus methodology (modified Delphi) to rate the appropriateness of imaging and treatment procedures by the panel. In those instances where evidence is lacking or not definitive, expert opinion may be used to recommend imaging or treatment.
authors.affiliation: Valley Hospital, Paramus, NJ 07652, USA. cmzelop@comcast.net
authors.forename: Carolyn M
authors.initials: CM
authors.lastname: Zelop
authors.forename: Marcia C
authors.initials: MC
authors.lastname: Javitt
authors.forename: Phyllis
authors.initials: P
authors.lastname: Glanc
authors.forename: Theodore
authors.initials: T
authors.lastname: Dubinsky
authors.forename: Mukesh G
authors.initials: MG
authors.lastname: Harisinghani
authors.forename: Robert D
authors.initials: RD
authors.lastname: Harris
authors.forename: Nadia J
authors.initials: NJ
authors.lastname: Khati
authors.forename: Donald G
authors.initials: DG
authors.lastname: Mitchell
authors.forename: Pari V
authors.initials: PV
authors.lastname: Pandharipande
authors.forename: Harpreet K
authors.initials: HK
authors.lastname: Pannu
authors.forename: Ann E
authors.initials: AE
authors.lastname: Podrasky
authors.forename: Thomas D
authors.initials: TD
authors.lastname: Shipp
authors.forename: Cary Lynn
authors.initials: CL
authors.lastname: Siegel
authors.forename: Lynn
authors.initials: L
authors.lastname: Simpson
authors.forename: Darci J
authors.initials: DJ
authors.lastname: Wall
authors.forename: Jade J
authors.initials: JJ
authors.lastname: Wong-You-Cheong
mesh_terms: D005317:Fetal Growth Retardation / Q000000981:diagnostic imaging*; D006801:Humans; D011871:Radiology / Q000592:standards*; D018570:Risk Assessment / Q000592:standards; D016216:Ultrasonography, Prenatal / Q000592:standards*; D014481:United States